Stopping Controversial Asthma Drugs Could Have Downside: Study – U.S. News & World Report

Stopping Controversial Asthma Drugs Could Have Downside: Study
U.S. News & World Report
The U.S. Food and Drug Administration has warned that asthma patients who take both long-acting beta-agonist and inhaled corticosteroid medications should be cautious about using them together once their condition is under control. Long-acting
Asthma Worsens with Step-Off TherapyMedPage Today
Study Questions Recommendation to Discontinue LABA Therapy in Asthma Science Daily (press release)

all 7 news articles »

View full post on asthma – Google News

Stopping Controversial Asthma Drugs Could Have Downside: Study – Newsday (subscription)


Newsday (subscription)

Stopping Controversial Asthma Drugs Could Have Downside: Study
Newsday (subscription)
It's OK for some patients with asthma to stick with a combination of medications instead of abandoning one because of concerns about complications, a new analysis of existing research suggests. The U.S. Food and Drug Administration has warned that

View full post on asthma – Google News

The downside of a good education: food allergies – National Post


National Post

The downside of a good education: food allergies
National Post
That finding gibes with some other studies, including one that indicated the prevalence of asthma among Chinese teenagers was lowest in those from mainland China, greater in residents of Hong Kong and highest in ethnic Chinese born in Canada.
Do You Know Your Food Allergies?dailyRx

all 3 news articles »

View full post on asthma – Google News